Table 3.
Immune evasion mechanisms employed by tumor cells and the tumor microenvironment
| Tumor cell-mediated mechanism(s) | ||
|---|---|---|
| TGF-β production | Inhibition of effector T cell functions | 123 |
| Indoleamine 2,3-dioxygenase expression | Depletion of tryptophan pool against T cells | 124,125 |
| PD-L1 expression | Suppression of effector T cells | 126,127 |
| p53 mutation | Deregulation of cell cycles and survival | 130 |
| Serine protease inhibitor PI-9/SPI-6 expression | Inhibition of granzyme B function | 131 |
| cFLIP over-expression | Blocking of death receptor-dependent tumor cell lysis pathway | 132 |
| Antigen epitope alteration | Escape from effector T cell recognition | 63,133 |
| Antigen loss | Escape from effector T cell recognition | 134,135 |
| Downregulation of MHC class I | Escape from effector T cell recognition | 136 |
| Overexpression of anti-apoptotic molecules | Survival from CTL-mediated apoptosis | 137 |
| Immune cell-mediated mechanism(s) | ||
| Tumor-associated macrophages | Suppression of effector T cells | Reviewed in138 |
| Regulatory T cells | Suppression of effector T cells | Reviewed in139 |
| Myeloid-derived suppressor cells | Suppression of effector T cells | Reviewed in140 |